Shenzhen Bioeasy Price To Book vs. Book Value Per Share
300942 Stock | 9.58 0.34 3.43% |
For Shenzhen Bioeasy profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shenzhen Bioeasy to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shenzhen Bioeasy Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shenzhen Bioeasy's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shenzhen Bioeasy Biotechnology over time as well as its relative position and ranking within its peers.
Shenzhen |
Shenzhen Bioeasy Bio Book Value Per Share vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Shenzhen Bioeasy's current stock value. Our valuation model uses many indicators to compare Shenzhen Bioeasy value to that of its competitors to determine the firm's financial worth. Shenzhen Bioeasy Biotechnology is number one stock in price to book category among its peers. It also is number one stock in book value per share category among its peers creating about 0.46 of Book Value Per Share per Price To Book. The ratio of Price To Book to Book Value Per Share for Shenzhen Bioeasy Biotechnology is roughly 2.19 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shenzhen Bioeasy by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shenzhen Bioeasy's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Shenzhen Book Value Per Share vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Shenzhen Bioeasy |
| = | 4.66 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Shenzhen Bioeasy |
| = | 2.13 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Shenzhen Book Value Per Share Comparison
Shenzhen Bioeasy is currently under evaluation in book value per share category among its peers.
Shenzhen Bioeasy Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Shenzhen Bioeasy, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shenzhen Bioeasy will eventually generate negative long term returns. The profitability progress is the general direction of Shenzhen Bioeasy's change in net profit over the period of time. It can combine multiple indicators of Shenzhen Bioeasy, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Operating Income | -66.9 M | -63.5 M | |
Income Before Tax | -177.8 M | -168.9 M | |
Net Income Applicable To Common Shares | 272 M | 285.6 M | |
Net Loss | -184.9 M | -175.7 M | |
Net Interest Income | -3.2 M | -3.1 M | |
Interest Income | 7.6 M | 7.9 M | |
Net Loss | -185 M | -175.7 M |
Shenzhen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Shenzhen Bioeasy. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shenzhen Bioeasy position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shenzhen Bioeasy's important profitability drivers and their relationship over time.
Use Shenzhen Bioeasy in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shenzhen Bioeasy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will appreciate offsetting losses from the drop in the long position's value.Shenzhen Bioeasy Pair Trading
Shenzhen Bioeasy Biotechnology Pair Trading Analysis
The ability to find closely correlated positions to Shenzhen Bioeasy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shenzhen Bioeasy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shenzhen Bioeasy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shenzhen Bioeasy Biotechnology to buy it.
The correlation of Shenzhen Bioeasy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shenzhen Bioeasy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shenzhen Bioeasy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shenzhen Bioeasy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Shenzhen Bioeasy position
In addition to having Shenzhen Bioeasy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Shenzhen Stock
To fully project Shenzhen Bioeasy's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shenzhen Bioeasy Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shenzhen Bioeasy's income statement, its balance sheet, and the statement of cash flows.